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Behavioral/Cognitive

Corticosterone Acts in the Nucleus Accumbens to Enhance
Dopamine Signaling and Potentiate Reinstatement of
Cocaine Seeking
Evan N. Graf, Robert A. Wheeler, David A. Baker, Amanda L. Ebben, Jonathan E. Hill, Jayme R. McReynolds,
Mykel A. Robble, Oliver Vranjkovic, Daniel S. Wheeler, John R. Mantsch,* and Paul J. Gasser*
Department of Biomedical Sciences, Marquette University, Milwaukee, Wisconsin 53201-1881

Stressful life events are important contributors to relapse in recovering cocaine addicts, but the mechanisms by which they influence
motivational systems are poorly understood. Studies suggest that stress may “set the stage” for relapse by increasing the sensitivity of
brain reward circuits to drug-associated stimuli. We examined the effects of stress and corticosterone on behavioral and neurochemical
responses of rats to a cocaine prime after cocaine self-administration and extinction. Exposure of rats to acute electric footshock stress
did not by itself reinstate drug-seeking behavior but potentiated reinstatement in response to a subthreshold dose of cocaine. This effect
of stress was not observed in adrenalectomized animals, and was reproduced in nonstressed animals by administration of corticosterone
at a dose that reproduced stress-induced plasma levels. Pretreatment with the glucocorticoid receptor antagonist RU38486 did not block
the corticosterone effect. Corticosterone potentiated cocaine-induced increases in extracellular dopamine in the nucleus accumbens
(NAc), and pharmacological blockade of NAc dopamine receptors blocked corticosterone-induced potentiation of reinstatement. Intraaccumbens administration of corticosterone reproduced the behavioral effects of stress and systemic corticosterone. Corticosterone
treatment acutely decreased NAc dopamine clearance measured by fast-scan cyclic voltammetry, suggesting that inhibition of uptake2mediated dopamine clearance may underlie corticosterone effects. Consistent with this hypothesis, intra-accumbens administration of
the uptake2 inhibitor normetanephrine potentiated cocaine-induced reinstatement. Expression of organic cation transporter 3, a
corticosterone-sensitive uptake2 transporter, was detected on NAc neurons. These findings reveal a novel mechanism by which stress
hormones can rapidly regulate dopamine signaling and contribute to the impact of stress on drug intake.

Introduction
Cocaine addicts report that craving responses to drug-associated
stimuli are intensified during periods of stress, resulting in
heightened susceptibility to relapse of drug use (Sinha, 2001; Hyman et al., 2006). These reports are paralleled by preclinical findings that stress can potentiate the reinstatement of compulsive
drug-seeking behavior by drug-associated cues in rodents (Shelton and Beardsley, 2005; Feltenstein and See, 2006; Buffalari and
See, 2009). Together, these studies suggest that stress may act as a
“stage-setter,” inducing state-dependent changes in the sensitivity of brain reward circuits to the reinforcing properties of drugs
(Preston and Epstein, 2011) and enhancing the potency of drugs
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of abuse or drug-associated cues to induce relapse. Thus, interactions between pathways activated by stress and by cocaineassociated stimuli are likely to be critical determinants of relapse
vulnerability. However, the potential mechanisms underlying
these interactions have not been well studied.
In addition to directly engaging motivational circuitry, stressful stimuli activate the hypothalamic-pituitary-adrenocortical
(HPA) axis, resulting in the release of glucocorticoid hormones,
corticosterone in rodents and cortisol in humans. Clinical and
preclinical studies suggest a complex relationship between glucocorticoids and drug relapse. In human addicts, stress-, cue-, and
drug-induced craving for cocaine is associated with elevated cortisol (Berger et al., 1996; Reid et al., 2003; Sinha et al., 2003) and
heightened HPA reactivity can predict relapse susceptibility
(Sinha et al., 2006, 2011; Fatseas et al., 2011; McKee et al., 2011).
In rodents, glucocorticoids can enhance behavioral and neurochemical responses to drugs of abuse (Piazza et al., 1996;
Marinelli et al., 1997; Barrot et al., 2000), but eliminating increases in glucocorticoids does not prevent stress- or cocaineinduced reinstatement of compulsive drug seeking in rats (Erb et
al., 1998; Mantsch et al., 2008; Graf et al., 2011) or cocaineinduced reinstatement in monkeys (Lee et al., 2003), and studies
examining the ability of elevated glucocorticoids alone to reinstate cocaine seeking have yielded mixed results (Deroche et al.,
1997; Lee et al., 2003; Shalev et al., 2003). Together, these studies
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indicate that, although glucocorticoids alone may not drive relapse, they do interact with drugs and drug-associated stimuli to
influence the likelihood of drug use. In the present studies, we
examined the effects of stress and glucocorticoids on the behavioral and neurochemical responses of rats to a relapse-promoting
stimulus.

Materials and Methods
Animals. Adult male Sprague Dawley rats (Harlan Laboratories), weighing 275–325 g, were housed individually in a temperature- and humiditycontrolled, Association for Assessment and Accreditation of Laboratory
Animal Care-accredited vivarium under a 12 h/12 h reversed light-dark
cycle (lights off at 0700 h) with ad libitum access to food and water.
Procedures were performed in accordance with the National Institutes of
Health Guide for the Care and Use of Laboratory Animals.
Jugular catheterization. Rats received indwelling jugular catheters under ketamine/xylazine (100 mg/kg; 2 mg/kg, i.p.) anesthesia as previously
described (Graf et al., 2011). Lines were connected to syringe pumps
(Razel) via fluid swivels (Instech Laboratory) suspended above the
chambers. Swivel/leash assemblies were balanced to permit unrestrained movement.
Cocaine self-administration, extinction, and reinstatement. Selfadministration was conducted using computer-interfaced operant conditioning chambers contained in sound-attenuating cubicles (Med
Associates). Rats were trained to self-administer cocaine (0.5 mg/kg/200
l, i.v.) by pressing a lever under a fixed ratio one schedule during daily
2 h sessions. Cocaine infusions were accompanied by illumination of a
light followed by a 25 s timeout period during which the light was extinguished but the lever remained extended. Responding on a second, inactive lever was also recorded. Once stable responding was observed
(⬍10% variation in daily responding over ⱖ3 consecutive sessions), rats
underwent an additional 14 daily self-administration sessions followed
by extinction training consisting of daily sessions during which the cocaine solution was replaced with saline. Once extinction criterion was
met (ⱕ10 active responses/session across 3 sessions), each rat was tested
for reinstatement. Reinstatement sessions were identical to extinction,
except that they were preceded by the delivery of an experimental treatment (e.g., footshock, corticosterone, or vehicle) followed by noncontingent intraperitoneal injection of cocaine (2.5 mg/kg) or saline.
Reinstatement was defined as an increase in responding on the lever
previously reinforced by cocaine compared with the preceding extinction
session. Inactive lever pressing was recorded during reinstatement but is
not reported because of a lack of significant effects.
Behavioral testing. Behavioral experiments were conducted during the
light phase. Each rat in the reinstatement experiments was tested four
times in a counterbalanced sequence, such that each rat received each
treatment. Between consecutive reinstatement tests, rats underwent additional extinction sessions until they again met extinction criterion.
Microdialysis. Drug-naive rats were anesthetized under ketamine/xylazine anesthesia and implanted with bilateral guide cannulae (20 gauge;
14 mm; Plastics One) directed at the nucleus accumbens (NAc), using the
following coordinates (Paxinos and Watson, 1998): ⫹0.9 mm AP, ⫾2.5
mm ML to bregma, ⫺4.4 mm from the surface of the skull, at an angle 6°
from vertical, and allowed to recover for 5 d. The night before testing, rats
were housed in self-administration chambers. The following day, microdialysis probes constructed as previously described (Madayag et al.,
2010) were inserted into guide cannulae and dialysis buffer (5 mM glucose, 140 mM NaCl, 1.4 mM CaCl2, 1.2 mM MgCl2, and 0.15% PBS, pH
7.4) was pumped through at a rate of 1 l/min for ⱖ3 h to allow neurotransmitter levels to stabilize. Samples were collected at 20 min intervals throughout the study. Dopamine concentrations were quantified by
comparing peak heights from samples and external standards using
HPLC coupled to electrochemical detection. The mobile phase consisted
of 15% acetonitrile, 10% methanol, 150 mM NaH2PO4, 4.76 mM citric
acid, 3 mM SDS, and 50 M EDTA, pH 5.6. Dopamine was separated
using a reversed-phase column (3 m; 80 ⫻ 3.2 mm; ESA) and detected
using an ESA Coulochem II detector coupled to two electrodes set a
t ⫺0.075 V and ⫹0.25 V, respectively.
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Table 1. Summary of treatment effects on plasma corticosterone concentrations

Vehicle
Cocaine (2.5 mg/kg)

Control

Electric footshock

Corticosterone
(2.0 mg/kg)

122 ⫾ 28
129 ⫾ 32

265 ⫾ 57
244 ⫾ 47

384 ⫾ 34
360 ⫾ 46

Experiment 1: effects of stress on cocaine-primed reinstatement. After
extinction training, rats (n ⫽ 7) were placed into self-administration
chambers for 15 min, during which they received either no shocks (control) or a series of intermittent uncontrollable electric footshocks (0.5
mA, 0.5 s duration, mean intershock interval ⫽ 40 s, range 10 –70 s)
through the grid floor. Response levers were retracted during this period.
After footshock, rats received an injection of cocaine (2.5 mg/kg, i.p.) or
saline, and were tested for reinstatement.
Experiment 2: effects of adrenalectomy on footshock- and cocaine-primed
reinstatement. After acquiring stable self-administration, rats (n ⫽ 6)
underwent bilateral adrenalectomy under ketamine/xylazine anesthesia
and were implanted with subcutaneous 25% corticosterone (SigmaAldrich) pellets in the nape of the neck, which results in plasma corticosterone concentrations approximating those observed at the nadir of the
diurnal cycle (Mantsch et al., 2008). Rats received 0.025% corticosterone
in the drinking water (ethanol concentration ⫽ 0.0001%). During the
active phase, when most drinking occurs, this elevates plasma corticosterone concentrations to those observed at the circadian peak (Mantsch et
al., 2008). Drinking water also contained 0.9% NaCl. Upon recovery, rats
underwent extinction training, followed by reinstatement testing.
Experiment 3: effects of corticosterone on basal and cocaine-primed reinstatement. After extinction training, adrenal-intact rats (n ⫽ 6) were
tested for reinstatement after an injection of corticosterone (2 mg/kg,
i.p.) or vehicle (0.03% EtOH, i.p.) 40 min before administration of cocaine (2.5 mg/kg, i.p.) or saline. This dose of corticosterone reproduces
electric footshock-induced plasma levels (Table 1).
Experiment 4: effects of RU38486 and corticosterone on cocaine-primed
reinstatement. To test the role of glucocorticoid receptor (GR) in
corticosterone-induced potentiation of reinstatement, adrenal-intact
rats (n ⫽ 10) received an injection of RU38486 (12.5 mg/kg, s.c.) or
vehicle (45% hydroxypropyl ␤-cyclodextrin) 1 h before intraperitoneal
administration of corticosterone (2 mg/kg) or vehicle (0.03% ethanol).
Forty minutes later, rats were tested for cocaine-induced reinstatement
(2.5 mg/kg, i.p.).
Experiment 5: effects of corticosterone on cocaine-induced increases in
NAc dopamine. After collection of baseline samples, rats received an injection of corticosterone (2.0 mg/kg, i.p.; n ⫽ 13) or vehicle (0.03%
EtOH; n ⫽ 12), followed 40 min later by an injection of cocaine (2.5
mg/kg, i.p.). Samples were collected for an additional 2 h. After the study,
rats were anesthetized with an overdose of pentobarbital (60 mg/kg, i.p.)
and transcardially perfused with 0.9% saline and 2.5% formalin. Brains
were removed, postfixed, and sectioned in the coronal plane (100 m)
for verification of probe placement.
Experiment 6: effects of intra-accumbens fluphenazine on corticosteroneinduced potentiation of cocaine-primed reinstatement. At the time of jugular implantation, rats received bilateral 11 mm, 26-gauge cannula aimed
0.5 mm above the target region, and the following coordinates were used
(Paxinos and Watson, 1998): core: anteroposterior (AP), ⫹1.0; mediolateral (ML), ⫾2.2; dorsoventral (DV), ⫺6.5 at 0°; shell: AP, ⫹2.5; ML,
⫾0.75; DV, ⫺6.5 at 0°. Rats received bilateral injections of the nonselective dopamine receptor antagonist, fluphenazine (30 nmol/0.3 l/side
over 1 min) or vehicle (aCSF) into the NAc core (n ⫽ 6) or shell (n ⫽ 7)
25 min after administration of corticosterone (2 mg/kg, i.p.) and 15 min
before low-dose cocaine (2.5 mg/kg, i.p.) administration and reinstatement testing.
Experiment 7: effects of intra-accumbens corticosterone on cocaineprimed reinstatement. Rats with cannulae aimed at the NAc core (n ⫽ 6)
or shell (n ⫽ 6) received intra-accumbens injections of hydroxypropyl
␤-cyclodextrin-complexed corticosterone (0.05 g/0.3 l/side over 1
min) or vehicle (aCSF) 15 min before administration of low-dose cocaine
(2.5 mg/kg, i.p.) or saline and reinstatement testing.
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Experiment 8: effects of intra-accumbens normetanephrine on cocaineprimed reinstatement. Rats with cannulae aimed at the NAc shell (n ⫽ 6)
received intra-accumbens injections of the nonglucocorticoid OCT3 inhibitor, normetanephrine (25 ng/0.3 l/side over 1 min) or vehicle
(aCSF) 15 min before administration of low-dose cocaine (2.5 mg/kg,
i.p.) or saline and reinstatement testing.
Voltammetry. Rats (n ⫽ 5 experimental, 5 control) were anesthetized
with urethane (1.5 g/kg, i.p.; Sigma-Aldrich) and placed in a stereotaxic
frame (David Kopf Instruments). AP, ML, and DV positions were referenced from bregma. The dura mater was punctured, carefully removed,
and a single carbon-fiber microelectrode was lowered into the NAc shell
(AP, ⫹1.7 mm; ML, ⫹0.8 mm; DV, 6.0 – 8.0 mm), coordinates taken
from an atlas of Paxinos and Watson (1998). The NAc shell was targeted
based on our previous studies, which demonstrated that, although OCT3
is expressed in both the core and shell of the NAc, it is expressed more
densely in the shell (Gasser et al., 2009). An Ag/AgCl reference electrode
was placed in the contralateral cortex. Electrical stimulation was accomplished with a bipolar, stainless-steel electrode (0.2 mm in diameter,
Plastics One) placed in the ventral tegmental area (AP, ⫺5.2 mm; ML,
⫹1.0 mm; DV, 8.0 –9.0 mm). The tips of the bipolar electrode were
separated by ⬃1.0 mm.
Electrical stimulation. Computer-generated stimulus trains (NL 800A,
Neurolog, Medical Systems) were optically isolated from the electrochemical system. Trains consisted of 24 biphasic pulses (300 A, 2 ms
each phase) with a stimulation frequency of 60 Hz applied through the
bipolar electrode. An interval of 3 min was allowed to elapse between
electrical stimulations to ensure reproducible catecholamine release with
each stimulation.
Voltammetric procedures. Voltammetric procedures have been described in detail previously (Heien et al., 2005). Briefly, glass-encased,
cylindrical carbon-fiber microelectrodes (T-650 carbon fibers, 5.1 m in
nominal diameter, Thornel, Amoco) with an exposed length of 75–100
m and Ag/AgCl reference electrodes were prepared. The fiber was held
at ⫺0.4 V against Ag/AgCl between scans and then driven to ⫹1.3 V and
back in a triangular fashion at 400 V/s for each voltammetric measurement. Application of this triangle waveform causes oxidation and reduction of chemical species that are electroactive within this potential range,
producing a change in current at the carbon fiber. Dopamine was identified by plotting changes in current against applied potential to produce
a cyclic voltammogram. Current arising from electrode surface processes
was subtracted as background. Background-subtracted cyclic voltammograms were obtained by digitally subtracting voltammograms collected
during stimulation from those collected during baseline recording. Voltammetric responses were viewed as color plots with the abscissa as voltage, the ordinate as acquisition time, and the current encoded in color.
Temporal responses were determined by monitoring the current at the
peak oxidation potential for dopamine by principal component regression (Heien et al., 2005). Because the carbon-fiber microelectrode was
used to lesion the brain and mark the precise recording site, postcalibration of the electrode was impossible. Instead, postcalibration factors/
carbon fiber area (6.9 ⫾ 0.3 pA/[mol/L ⫻ m 2]) were used on the basis
of the average response data obtained from calibrating multiple electrodes in the manner of Park et al. (2010).
Data analysis. The Demon Voltammetry software suite was used to
analyze all data in the manner of Yorgason et al. (2011).  was extrapolated from an exponential fit of the decay curve, as the point of 63.2%
decline in the signal. Full-width at half-height was defined as the time
between the midpoint of decline of the decay curve extended back in time
to the intersecting point of incline of the ascending curve of the dopamine signal. Km is the apparent affinity of dopamine for transporters,
solved for from the Michaelis-Menten equation (Wightman et al., 1988;
Yorgason et al., 2011). The decay times 20 and 80 were defined as the
time to 20% and 80% signal reductions in the decay curve. Data are
represented as mean change after treatment ⫾ SEM.
Immunofluorescence. For immunodetection of OCT3, an affinityisolated antibody (rabbit anti-OCT3, catalog #OCT31A, Alpha Diagnostics International) raised against an 18-amino acid sequence
in the large intracellular loop of rat OCT3 (amino acids 313–330:
HLSSNYSEITVTDEEVSN) was used. This amino acid sequence is 100%

conserved in mouse and rat OCT3 and has no significant sequence homology with other OCTs or with any organic cation/carnitine transporters. The specificity of this antibody was confirmed previously in
immunohistochemical and immunofluorescence applications (Vialou et
al., 2004; Lips et al., 2005; Gasser et al., 2006, 2009). Additional proteins
were detected using primary antibodies directed against tyrosine hydroxylase (MAB 318, Millipore; diluted 1:1600), dopamine D1 receptor
(MAB 5290, Millipore; diluted 1:500), and ␤-III tubulin (ab 7751,
Abcam; diluted 1:1200). Primary antibodies were detected using
AlexaFluor-594-conjugated donkey anti-rabbit and AlexaFluor-488conjugated donkey anti-mouse IgG antibodies (1:200; Invitrogen). Photomicrographs were acquired using a Retiga 2000R digital camera
(QImaging) on a Nikon 80i microscope using NIS Elements software
(Nikon Instruments). Each combination of antibodies was used in at
least three independent studies with similar results.
Statistical analysis. Statistical analyses were conducted using IBM SPSS
Statistics software. Sample sizes (n) were determined by expected effect
sizes and the power of the analysis. Statistical significance was determined using ANOVA or Student’s t tests (two-tailed) followed, when
appropriate, by further analyses of main effects using ANOVA and/or
post hoc testing using Bonferroni-corrected t tests. Normality testing for
all data was conducted using the Shapiro-Wilk test; and in all cases, data
were determined to be sufficiently normal to merit parametric analysis.
For within-subjects analyses, sphericity of data was confirmed using the
Mauchly’s test. For between-subjects analyses, homogeneity of data was
confirmed using the Levene’s test.

Results
Stress and corticosterone potentiate cocaine-induced
reinstatement of drug-seeking behavior
We demonstrate here that a dose of cocaine (2.5 mg/kg, i.p.),
which is insufficient to reinstate extinguished cocaine seeking
under baseline conditions, produces robust reinstatement when
delivered after exposure to an acute stressor, uncontrollable electric footshock. Significant reinstatement was observed when rats
were tested for cocaine-induced reinstatement after footshock
( post hoc, p ⫽ 0.034 vs extinction) but not when rats received
cocaine alone or footshock in combination with a saline injection
(two-way ANOVA; significant footshock ⫻ reinstatement condition interaction: F(3,18) ⫽ 3.424; p ⫽ 0.04) (Fig. 1A).
To test the hypothesis that the observed potentiation of reinstatement by footshock was mediated by elevated corticosterone,
we conducted two experiments. First, we tested for footshockpotentiated reinstatement in a group of adrenalectomized rats in
which plasma corticosterone concentrations were maintained at
basal (nonstress) concentrations. Adrenalectomy was performed
after acquisition of self-administration but before reinstatement
testing. Footshock failed to potentiate cocaine-induced reinstatement in adrenalectomized rats (two-way ANOVA; no significant
footshock ⫻ reinstatement condition interaction: F(3,21) ⫽ 0.976;
p ⫽ 0.423) (Fig. 1B), indicating that stress-induced potentiation
of cocaine-seeking behavior requires elevation of corticosterone
concentrations to stress levels. Second, we examined (in adrenalintact rats) the effects of acute stress-level corticosterone treatment on cocaine-primed reinstatement in the absence of stress.
In this study, administration of corticosterone at a dose (2 mg/kg,
i.p.) that produced stress levels in plasma (Table 1) was sufficient
to potentiate cocaine-induced reinstatement in the absence of
stress (Fig. 1C). Like footshock, corticosterone alone (before a
saline injection) failed to reinstate cocaine seeking but potentiated reinstatement in response to low-dose cocaine (two-way
ANOVA, significant corticosterone treatment ⫻ reinstatement
condition interaction: F(3,15) ⫽ 20.997; p ⫽ 0.001). When administered alone, neither corticosterone nor low-dose cocaine produced significant reinstatement. However, the combination of
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locates hippocampal GR from cytosolic to
nuclear fractions (Spiga et al., 2010), GR immunostaining in the hippocampi of RU486treated rats was concentrated in cell nuclei,
whereas GR in vehicle-treated rats was observed as diffuse cellular staining (data not
shown), indicating that treatment with
RU486 at this dose and via this route of administration resulted in occupation of central GR.
Corticosterone-dopamine interactions
in the NAc underlie potentiation
of reinstatement
Activation of dopamine receptors in subregions of the NAc is sufficient to reinstate
drug seeking in rats (Cornish and Kalivas,
2000; Bachtell et al., 2005; Schmidt et al.,
2006), and the magnitude of the cocaineinduced increase in accumbens dopamine
appears to be a key determinant of the
magnitude of reinstatement (Madayag et
al., 2010). Previous reports have demonstrated that evoked increases in NAc
dopamine are enhanced when corticosterone is elevated to stress concentrations at
the time of testing (Piazza et al., 1996;
Figure 1. Stress potentiates cocaine-induced drug-seeking behavior by a corticosterone-dependent, GR-independent mecha- Deroche et al., 1997; Marinelli et al.,
nism. A, B, Cocaine lever responses on the last day of extinction and during reinstatement testing of (A) adrenal-intact (n ⫽ 7) or 1997), suggesting that the potentiating ef(B) adrenalectomized (ADX; n ⫽ 6) rats. On the day of reinstatement testing, rats were subjected to 15 min of uncontrollable,
fects of corticosterone and stress on cointermittent electric footshock (EFS) or no shock, followed by injection of cocaine (2.5 mg/kg, i.p.) or saline, and cocaine lever
responses were recorded for 2 h. C, Cocaine lever responses on the last day of extinction and during reinstatement testing. Rats caine seeking may involve augmentation
(n ⫽ 6) received an injection of corticosterone (CORT; 2.0 mg/kg, i.p.) or vehicle, followed 40 min later by an injection of cocaine of the NAc dopamine response to cocaine.
(2.5 mg/kg, i.p.) or saline. D, Cocaine lever responses on the last day of extinction and during reinstatement testing. Rats (n ⫽ 10) To test this hypothesis, we used in vivo
received an injection of the glucocorticoid receptor antagonist RU38486 (12.5 mg/kg, s.c.) or vehicle, followed 60 min later by microdialysis to examine the effects of
injection of corticosterone (2.0 mg/kg, i.p.) or vehicle, followed 40 min later by an injection of cocaine (2.5 mg/kg, i.p.) (see also stress-level corticosterone treatment on
Table 1). *p ⬍ 0.05, significantly different from extinction responding. Error bars represent mean ⫾ SEM.
cocaine-induced increases in extracellular
dopamine concentrations in the NAc. Figcorticosterone pretreatment followed by low-dose cocaine proure 2A illustrates extracellular dopamine levels in the NAc before
duced robust reinstatement ( p ⫽ 0.003 vs extinction).
and after intraperitoneal injection of low-dose cocaine (2.5 mg/
kg) in animals pretreated with stress-level corticosterone (2 mg/
Role of the glucocorticoid receptor in corticosterone-induced
kg, i.p.) or vehicle. Cumulative postcocaine extracellular
potentiation of drug-seeking
dopamine levels (calculated as areas under the curve using all
Although many actions of corticosteroids require activation of
postcocaine samples) were significantly higher in corticosteronethe GR, some acute actions appear to be mediated by GRpretreated rats relative to vehicle controls (Fig. 2B; unpaired
independent mechanisms (Di et al., 2003). To determine the cont test, t(23) ⫽ 1.793, p ⫽ 0.043).
tribution of GR-dependent signaling to corticosterone effects on
Based on these findings, we hypothesized that the observed
reinstatement, we examined the effects of pretreatment with the
corticosterone-potentiated increase in NAc dopaminergic neuGR antagonist RU486 on corticosterone-induced potentiation of
rotransmission was responsible for the potentiating effects of
cocaine-primed reinstatement. In reinstatement studies, precorticosterone on cocaine-induced reinstatement. To test this
treatment with RU486 (12.5 mg/kg, s.c.) failed to block the pohypothesis, we examined the effects of bilateral intra-accumbens
tentiation of low-dose cocaine-induced reinstatement by
infusions of the nonselective dopamine receptor antagonist flucorticosterone administration (Fig. 1D). Once again, corticostephenazine or vehicle on corticosterone-induced potentiation of
rone potentiated reinstatement after low-dose cocaine adminiscocaine-primed reinstatement. Intra-accumbens fluphenazine
tration (three-way ANOVA, significant corticosterone ⫻
treatment prevented the increase in reinstatement that was obreinstatement condition interaction: F(1,9) ⫽ 11.141, p ⫽ 0.009).
served when rats received both corticosterone and low-dose
RU-486 treatment did not disrupt this effect (significant main efcocaine (Fig. 3A; two-way ANOVA; significant treatment ⫻ refects or interactions involving RU-486 were not found), indicating
instatement condition interaction: F(1,12) ⫽ 6.007; p ⫽ 0.031).
that corticosterone’s potentiating action involves a GRLow-dose cocaine administration after corticosterone pretreatindependent, nongenomic mechanism. To confirm that the dose of
ment reinstated cocaine seeking after delivery of vehicle ( p ⫽
RU486 (12.5 mg/kg) used in this study resulted in occupation of
0.007), but not fluphenazine, into the NAc. Subgroups of rats
central GR, we examined the effects of RU486 on subcellular localreceived injections targeting the NAc core and shell. Because the
ization of GR in hippocampal cells using immunofluorescence.
Consistent with previous studies demonstrating that RU486 transeffects of fluphenazine on reinstatement did not differ between
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Figure 2. Corticosterone potentiates cocaine-induced increases in extracellular dopamine concentrations in the NAc. A, In vivo microdialysis was used to measure extracellular dopamine levels
in the NAc in drug-naive rats. After collection of baseline samples, rats received an injection of corticosterone (2.0 mg/kg, i.p.; n ⫽ 13; F) or vehicle (n ⫽ 12; E) at the time indicated. Forty minutes
later, all animals received an injection of cocaine (2.5 mg/kg, i.p.). Data represent mean dopamine concentrations at each time point. B, Cumulative dopamine (area under the curve) during the
postcocaine period (t ⫽ 40 –160 min). *p ⬍ 0.05, significantly different from the vehicle group (unpaired t test). C, Black lines indicate the locations of the microdialysis probes aimed at the NAc.

Figure 3. Dopamine-dependent actions in the NAc underlie corticosterone-induced potentiation of drug-seeking behavior. A, Cocaine lever responses on the last day of extinction and during
reinstatement testing. Rats (n ⫽ 13) received an intraperitoneal injection of corticosterone (2 mg/kg). After 25 min, all animals received intra-accumbens injections of fluphenazine (30 nmol/0.3
l) or vehicle followed, 15 min later, by an intraperitoneal cocaine injection (2.5 mg/kg). *p ⬍ 0.05, significantly different from extinction responding. #p ⬍ 0.05, significantly different from
reinstatement responding after vehicle treatment. ns, Not significant. B, Cocaine lever responses on the last day of extinction and during reinstatement testing. On the day of reinstatement testing,
rats (n ⫽ 12) received intra-accumbens injections of corticosterone (CORT, 0.05 g/0.3 l) followed, 15 min later, by an intraperitoneal injection of saline or cocaine (2.5 mg/kg). *p ⬍ 0.05,
significantly different from extinction responding). C, Locations of microinjection sites from animals used in A and B.

these two brain regions, data from the two regions were combined for analysis.
Corticosterone acts in the NAc to potentiate reinstatement
Because we found that (1) corticosterone acutely potentiates
cocaine-induced increases in extracellular dopamine in the NAc
and (2) dopaminergic neurotransmission in the NAc is necessary
for corticosterone-induced potentiation of behavior, we sought
to determine whether corticosterone actions within the NAc are
sufficient to promote reinstatement. To accomplish this, we
tested the ability of intra-accumbens corticosterone infusions to
reproduce the effects of systemic corticosterone or footshock on
low-dose cocaine-induced reinstatement. As was the case with
the fluphenazine study, subgroups of rats received infusions of
corticosterone or vehicle into the NAc shell or core; and because
the effects of corticosterone administered into the shell or core
did not differ, data from the two regions were combined for
analysis. As in the systemic corticosterone experiments, neither
low-dose cocaine (after intra-accumbens vehicle) nor intraaccumbens corticosterone (before intraperitoneal saline administration) reinstated cocaine seeking when administered alone.
However, when rats received bilateral intra-accumbens corticosterone before administration of low-dose cocaine, significant

reinstatement was observed (two-way ANOVA, significant treatment ⫻ reinstatement condition interaction: F(2,22) ⫽ 4.182; p ⫽
0.029; post hoc testing p ⫽ 0.01 vs extinction) (Fig. 3B).
Effects of acute corticosterone treatment on dopamine
clearance in the NAc
Together, our results demonstrate that corticosterone acutely potentiates cocaine-induced dopamine signaling in the NAc and
that this potentiation promotes cocaine seeking. However, corticosterone alone has no effect on extracellular dopamine and does
not induce cocaine seeking. Further, this effect appears to occur
independently of GR activation, suggesting a rapid, nongenomic
mechanism of action. Such a mechanism, which would enhance
cocaine effects on dopaminergic neurotransmission without directly driving increases in dopamine, could involve either inhibition of dopamine metabolism or of transporter-mediated
clearance. Corticosteroids have long been known to acutely block
catecholamine clearance mediated by uptake2, a high-capacity
monoamine transport system originally described in peripheral
tissues (Iversen and Salt, 1970). Uptake2 activity has more recently been attributed to a group of broadly specific transporters,
including the organic cation transporter (OCT) family (OCTs 1,
2, and 3) and the plasma membrane monoamine transporter
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Figure 4. Corticosterone administration decreases dopamine uptake after DAT blockade. A, NAc recording sites for dopamine uptake measurements in vehicle-treated (E) and corticosteronetreated (F) rats. B, Experimental design and example of two-dimensional color representation of cyclic voltammetric data collected for 20 s around a single stimulation. The ordinate is the applied
voltage (Eapp), and the abscissa is time (in seconds). Changes in current at the carbon-fiber electrode are indicated in color. After 10 baseline stimulations (white horizontal lines), rats were injected
with GBR12909 (15 mg/kg) and stimulated until stabilization of the drug response (center color plot). Rats were then either injected with corticosterone (2 mg/kg, n ⫽ 5, right color plot, top), or
vehicle (n ⫽ 5, right color plot, bottom). C, Measures of dopamine uptake. D–F, Mean ⫾ SEM change in measures of uptake after corticosterone treatment (D, FWHH; E, ; and F, apparent Km),
compared with vehicle-injected controls. *p ⬍ 0.05, compared with vehicle (Student’s unpaired t test).

(PMAT). All of these transporters are capable of transporting,
with varying efficiencies, dopamine and other monoamines
(Grundemann et al., 1998b; Shang et al., 2003; Gorboulev et al.,
2005; Schomig et al., 2006; Duan and Wang, 2010) and, with the
exception of OCT1, all are expressed in the brain (Engel et al.,
2004; Vialou et al., 2004; Amphoux et al., 2006; Gasser et al.,
2009). Although all are sensitive to inhibition by corticosterone,
their sensitivities vary widely. PMAT is the least sensitive to corticosterone (Ki ⫽ 450 M), followed by OCT1 (IC50 ⫽ 150 M),
OCT2 (IC50 ⫽ 5 M), and OCT3 (IC50 ⫽ 0.04 – 0.2 M) (Grundemann et al., 1998b; Shang et al., 2003; Gorboulev et al., 2005;
Schomig et al., 2006; Duan and Wang, 2010). Recent studies have
demonstrated that corticosterone inhibition of OCT-mediated
transport occurs by direct binding to the transporter, through a
GR-independent, nongenomic mechanism (Grundemann et al.,
1999; Horvath et al., 2003; Gorboulev et al., 2005).
To test the hypothesis that the potentiation of cocaine-primed
reinstatement by corticosterone involves blockade of dopamine
clearance, we used fast-scan cyclic voltammetry, an electrochemical technique with the temporal resolution necessary for resolving dopamine release and uptake (Wightman et al., 1988).
Dopamine release was electrically evoked in anesthetized rats by
stimulating dopamine neurons in the ventral tegmental area

while uptake was measured in the NAc shell under transport
saturating conditions, permitting Michaelis-Menten kinetic
modeling (Wightman et al., 1988; Yorgason et al., 2011). Electrically evoked dopamine release and uptake were measured in the
NAc in drug naive rats to establish a baseline (Fig. 4). All rats then
received an injection of GBR12909 (15 mg/kg, i.p.), an inhibitor
that, unlike cocaine, selectively blocks the dopamine transporter
(DAT) and reliably reduces dopamine clearance (Andersen,
1989; Park et al., 2010). We observed the GBR12909-induced
reduction in DA clearance to be stable on a time scale consistent
with previous reports (Budygin et al., 2000; Espana et al., 2008;
Park et al., 2010), and we verified stability of the pharmacological
effect of GBR12909 as a persistent increase in both amplitude and
duration of the stimulated dopamine signal. After stabilization of
the response, rats received an additional injection either of corticosterone (2 mg/kg), or vehicle to test the hypothesis that corticosterone treatment would further augment the dopamine
signal.
Electrical stimulation of dopamine neurons in the VTA reliably induced dopamine release in the NAc (Fig. 4B). This effect
was augmented by blocking the DAT with GBR12909. After stabilization of the GBR effect, injection of corticosterone at a dose
that reproduces stress-induced plasma levels (Table 1) further
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Table 2. Summary of treatment effects on measures of dopamine clearance in the NAc

Vehicle
Corticosterone

⌬ Full-width at
half-height (s)

⌬ Tau (s)

⌬ Apparent Km (nM)

⌬ Half-life (ms)

⌬ t20 (ms)

⌬ t80 (ms)

⌬ Peak height
关DA兴 (nM)

⫺0.102 (0.06931)
0.48 (0.11353)

⫺0.036 (0.05887)
0.532 (0.2067)

⫺86.118 (96.09)
492.282 (117.814)

⫺0.02 (0.03937)
0.368 (0.14267)

⫺0.018 (0.09074)
0.284 (0.09293)

⫺0.094 (0.09796)
1.122 (0.51043)

⫺0.68 (0.16775)
0.69 (0.51905)

augmented the dopamine signal (Fig.
4B–D; Table 2). Kinetics of dopamine
transport were modeled with the Demon
Voltammetry and Analysis software suite.
Several measures of uptake were analyzed
(Fig. 4; Table 2) with each measure in
agreement, consistent with previous studies (Yorgason et al., 2011). Corticosterone
treatment significantly increased fullwidth at half-height (t(8) ⫽ ⫺4.375, p ⫽
0.002, Fig. 4D),  (t(8) ⫽ ⫺2.643, p ⫽ 0.03,
Fig. 4E), and apparent Km (t(8) ⫽ ⫺3.804,
p ⫽ 0.005, Fig. 4F ), compared with
vehicle-injected controls, indicating a reduction in dopamine clearance.
Intra-accumbens normetanephrine
Figure 5. Normetanephrine potentiates cocaine-induced drug-seeking behavior. A, Effects of intra-accumbens normetanephpotentiates
rine on cocaine-primed reinstatement. Rats (n ⫽ 6) received bilateral infusions of normetanephrine (25 ng/0.3 l) or vehicle
cocaine-induced drug seeking
(aCSF) followed, 15 min later, by an injection of cocaine (2.5 mg/kg, i.p.) or saline. Data represent mean ⫾ SEM of active lever
Although the results of the voltammetry responding over the 2 h immediately after the second injection. Significant increases in active lever responding were observed only
studies strongly suggest that corticoste- when animals had received both normetanephrine and cocaine. *p ⬍ 0.05, compared with all other groups. B, Locations of
rone acts at least in part by inhibiting do- microinjection sites from animals used in B.
pamine clearance, there are additional
2006; Duan and Wang, 2010; Hill et al., 2011). Thus, we hypothGR-independent mechanisms through
esized that the acute corticosterone-induced inhibition of dopawhich glucocorticoids may alter neurotransmission (Di et al.,
mine clearance in the NAc reported here is the result of inhibition
2003). To more rigorously test our hypothesis that uptake inhiof OCT3-mediated transport. Although our previous studies idenbition mediates the potentiating effects of stress and corticosterone
tified OCT3-expressing cells in the NAc (Gasser et al., 2009), the
on cocaine seeking, we examined the ability of intra-accumbens adidentity of these cells is unknown, and there is no information availministration of normetanephrine, the O-methylated metabolite of
able about the distribution of OCT3 with respect to dopaminergic
norepinephrine and a potent nonglucocorticoid inhibitor of
terminals and dopamine receptors. In the present studies, we used
uptake2-mediated transport (Martel et al., 1999), to reproduce the
immunofluorescence techniques to confirm the expression of OCT3
effects of corticosterone and footshock on low-dose cocainein the NAc, to identify the phenotype of OCT3-expressing cells, and
induced reinstatement. Although normetanephrine has been reto describe the localization of OCT3 immunoreactivity in relation to
ported to act as a weak agonist at ␣1-adrenergic receptors (Langer
dopaminergic terminals and dopamine receptors in the region.
and Rubio, 1973), to our knowledge the sole overlapping mechaOCT3-like immunoreactivity was observed as punctae distributed
nism of action between normetanephrine and glucocorticoids is
throughout the NAc core and shell, and was also concentrated in
blockade of uptake2-mediated transport. Based on our demonstrasmall-diameter (8 –10 m) perikarya (Fig. 6). Staining was not obtion that corticosterone decreased dopamine clearance in the NAc
served in sections incubated in the absence of the OCT3 antibody
shell, and on our previous studies demonstrating that, although
(data not shown). In both regions, OCT3-ir punctae were observed
OCT3 is expressed in both the shell and core of the NAc, it is exin close proximity to, but not colocalized with, tyrosine hydroxylasepressed more densely in the shell (Gasser et al., 2009), our injections
immunoreactive fibers (Fig. 6A,B), and were observed in close proxof normetanephrine were targeted to the shell (Fig. 5). Like intraimity to dopamine D1 receptor-immunoreactive punctae (Fig. 6C).
accumbens corticosterone, intra-accumbens normetanephrine
OCT3-immunoreactive perikarya also displayed immunoreactivity
potentiated low-dose cocaine-induced reinstatement but had no effor the neuron-specific cytoskeletal marker ␤-III tubulin (Fig. 6D).
fect on cocaine seeking when administered alone (two-way
ANOVA, significant treatment ⫻ reinstatement condition interacDiscussion
tion: F(2,8) ⫽ 8.765; p ⫽ 0.01) (Fig. 5). Post hoc testing indicated that
Our findings provide new insight into the mechanisms by which
intra-accumbens normetanephrine infusions potentiated cocainestressful life events increase the likelihood of relapse in recovering
induced reinstatement (p ⫽ 0.01 vs extinction).
addicts. The data establish that acute stress potentiates the effects
of low-dose cocaine on drug-seeking behavior in rats, and idenOCT3 is expressed on NAc neurons
tify corticosterone as a necessary mediator of this potentiating
The uptake2 transporters vary widely in their sensitivity to inhiinteraction. They identify the NAc as a critical site at which
bition by corticosterone. Of these transporters, OCT3 is by far the
corticosterone acts to potentiate cocaine effects on dopaminergic
most sensitive to inhibition by corticosterone and is the only
signaling and reinstatement. They demonstrate that corticostetransporter inhibited by corticosterone at physiological concenrone acutely decreases dopamine clearance within the NAc, and
trations (Shang et al., 2003; Gorboulev et al., 2005; Gasser et al.,
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Figure 6. OCT3 is expressed proximal to dopamine terminals and D1 receptors in the NAc. A, B, Representative photomicrographs depicting immunostaining for OCT3 (red) and tyrosine
hydroxylase (green) in adult rat NAc core (A) and shell (B). C, Immunostaining for OCT3 (red) and dopamine D1 receptor (green) in NAc core. Square in C indicates area shown at higher magnification
in the inset. D, Immunostaining for OCT3 (red) and the neuronal marker B-III tubulin (green) in NAc core. E, Line drawing (adapted from Paxinos and Watson, 1998) of a coronal section containing
the areas of the NAc used for immunostaining and depicted in the indicated panels. Labeled black rectangles indicate the approximate locations from which the images were acquired. Scale bars:
A, B, 33.3 m; C, D, 20 m; D inset, 6.75 m.

provide evidence that corticosterone acts by inhibiting the highcapacity monoamine transporter OCT3. We conclude that
corticosterone-induced inhibition of dopamine clearance increases sensitivity to the effects of cocaine on dopaminergic neurotransmission and behavior and may represent a fundamental
mechanism through which stress modulates dopaminergic neurotransmission, resulting in alterations in motivated behavior.
Although acute stress can, under certain conditions, act as a
primary trigger for the reinstatement of drug-seeking behavior
(Erb et al., 1998; Graf et al., 2011), it has been proposed that stress
more often acts as a “stage-setter,” increasing the likelihood of
relapse in response to other drug-associated stimuli (Preston and
Epstein, 2011). The present studies model the stage-setting actions of stress and demonstrate that, even under conditions when
stress alone does not trigger reinstatement, it can potentiate
reinstatement in response to another subthreshold stimulus.
Furthermore, these studies demonstrate that the stage-setting
actions of stress are mediated by a mechanism distinct from that
underlying reinstatement triggered by stress alone. Specifically,
reinstatement induced primarily by stress does not require increases in corticosterone to stress levels (Erb et al., 1998; Graf et
al., 2011). In contrast, the potentiation of cocaine-induced reinstatement by stress requires elevation of corticosterone to stress
levels, and treatment with stress levels of corticosterone in the
absence of stress is sufficient to potentiate cocaine-induced reinstatement. Thus, although stress-induced increases in corticosterone do not by themselves drive reinstatement of drug-seeking
behavior, they appear to enhance sensitivity to other relapsepromoting stimuli. This may represent an important mechanism
by which stress influences the likelihood of relapse in recovering
addicts. Given that a history of exposure to cocaine and other
drugs of abuse can alter HPA axis function (for review, see Kreek
and Koob, 1998) and determines the pattern and magnitude of
drug seeking and/or self-administration (Ahmed and Koob,
1998; Mantsch et al., 2008), the present findings suggest the following: (1) altered HPA reactivity and glucocorticoid regulation

of dopamine clearance may contribute to the transition to compulsive use that defines addiction; and (2) the contribution of this
mechanism to drug use may vary depending on the drug and the
phase of the addiction process.
Our data indicate that corticosterone enhances the behavioral
effects of low-dose cocaine by potentiating cocaine-induced increases in NAc dopamine. Dopamine signaling in the NAc is an
important contributor to cocaine-induced reinstatement of drug
seeking (Cornish and Kalivas, 2000; Bachtell et al., 2005; Schmidt
et al., 2006); and the magnitude of cocaine-primed reinstatement
appears to be determined in part by the level of extracellular
dopamine in the NAc (Madayag et al., 2010). Our findings are
consistent with this model and strongly suggest that the potentiation of relapse by stress or corticosterone is mediated by augmentation of cocaine-induced increases in NAc dopamine. In the
present studies, noncontingent injection of low-dose cocaine was
insufficient either to elevate NAc dopamine or to induce reinstatement of compulsive drug-seeking unless it was preceded by
elevation of corticosterone to stress levels, either by acute stress
exposure or by corticosterone injection. Furthermore, elevation
of corticosterone within the NAc was sufficient to potentiate subthreshold cocaine-induced reinstatement, and the ability of systemic corticosterone to potentiate cocaine-primed reinstatement
was eliminated by intra-accumbens blockade of dopamine receptors. These results are consistent with previous studies demonstrating that removal of corticosterone by adrenalectomy or
metyrapone treatment blunts cocaine-induced increases in NAc
dopamine (Rouge-Pont et al., 1995; Barrot et al., 2000).
Our finding that stress-level corticosterone treatment potentiated cocaine-induced increases in NAc dopamine, but
had no effect on its own, is consistent with the results of previous studies demonstrating that corticosterone-induced increases in striatal dopamine concentrations are state-dependent
(Piazza et al., 1996). This state dependency led to the hypothesis
that corticosterone does not directly stimulate dopamine release
in the NAc but rather acts indirectly to enhance dopaminergic
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responses to other stimuli (e.g., by inhibiting catabolic enzymes
or uptake mechanisms) (Piazza et al., 1996). Under this hypothesis, corticosterone effects on NAc dopamine would require a
threshold level of activity of dopaminergic inputs. Below this
threshold, corticosterone would have little effect on dopamine
concentrations.
The results of our voltammetry studies demonstrate that corticosterone treatment rapidly decreases dopamine clearance in
the NAc. This is consistent with previous ex vivo findings that
glucocorticoids rapidly decrease the uptake of dopamine by
crude striatal synaptosomes (Gilad et al., 1987), a preparation
that contains both presynaptic and postsynaptic compartments.
The rapidity with which glucocorticoids decreased uptake in our
studies and in the ex vivo studies indicates that corticosteroneinduced decreases in dopamine clearance involve a nongenomic
mechanism. This is consistent with our finding that the GR antagonist RU38486 did not block corticosterone-induced potentiation of
cocaine-primed reinstatement. The ability of corticosterone to decrease dopamine clearance in animals in which the activity of the
DAT was inhibited by treatment with a saturating dose of GBR12909
indicates that corticosterone-sensitive dopamine clearance does not
involve the DAT. These findings suggest that corticosterone decreases extracellular dopamine clearance either by inhibiting dopamine catabolism or by blocking a non-DAT dopamine transporter.
Although recent studies have demonstrated acute glucocorticoidinduced decreases in monoamine oxidase protein and activity, these
effects were only observed after 2– 4 h of glucocorticoid exposure
(Soliman et al., 2012), well beyond the time points for measurement
of uptake and behavior in the current studies. Thus, the most likely
mechanism involves inhibition of dopamine transport.
Our finding that intra-accumbens administration of
normetanephrine, a nonglucocorticoid inhibitor of uptake2mediated transport (Martel et al., 1999), mimicked the effects of
corticosterone on cocaine-induced reinstatement, strongly suggests that the behavioral and physiological effects of corticosterone reported here result from corticosterone-induced inhibition
of dopamine clearance mediated by an uptake2 transporter. Uptake2 is a high-capacity, corticosteroid-sensitive monoamine
transport system originally described in peripheral tissues
(Iversen and Salt, 1970). Recent studies have identified a small
group of transporters, including OCTs 1, 2, and 3 and PMAT, as
mediators of uptake2-like monoamine transport and have demonstrated their expression in the brain (Engel et al., 2004; Vialou
et al., 2004; Amphoux et al., 2006). Of these transporters, OCT3
and PMAT transport dopamine with the greatest efficiency,
whereas OCT1 and 2 are not thought to transport dopamine
under physiological conditions (Grundemann et al., 1998a, b,
1999; Engel et al., 2004; Duan and Wang, 2010; Bacq et al., 2011).
OCT3 and PMAT transport dopamine with similar efficiencies,
but they differ markedly in sensitivity to inhibition by corticosterone. Whereas the IC50 for corticosterone inhibition of OCT3mediated transport (0.04 – 0.2 M) (Shang et al., 2003) is within
the physiological range reported for stress-induced concentrations of corticosterone in the brain (Droste et al., 2008), PMATmediated transport is inhibited only at very high concentrations
of corticosterone (Ki ⫽ 450 M) (Duan and Wang, 2010). Based
upon these properties, we hypothesize that OCT3 inhibition underlies the effects of stress level corticosterone treatment on dopamine clearance and cocaine-seeking behavior in the present
studies. Definitive testing of this hypothesis will require the examination of stress and corticosterone effects on drug-seeking
behavior and dopamine clearance in OCT3-deficient animals.
Consistent with our hypothesis, OCT3-deficient mice exhibit en-

hanced behavioral and neurochemical responses to methamphetamine and cocaine (Vialou et al., 2008; Cui et al., 2009).
The results of our immunofluorescence studies suggest that
OCT3 represents a postsynaptic dopamine clearance mechanism
in the NAc. We confirmed the expression of OCT3 in the core
and shell of the rat NAc, and we began to characterize the phenotype of OCT3-expressing cells and the subcellular localization of
OCT3 in this area. Our observations indicate that OCT3 is expressed on the somata and processes of postsynaptic, likely medium spiny neurons in the NAc, and not on dopaminergic
terminals. As in the amygdala (Hill and Gasser, 2013), OCT3 in
the NAc is localized in close proximity to D1 receptors. These
findings raise the interesting possibility that OCT3 represents a
previously uncharacterized postsynaptic dopamine clearance
mechanism, and make OCT3 a compelling mechanism through
which glucocorticoids may act to potentiate cocaine effects on
dopaminergic neurotransmission and behavior. Additional studies, including electron microscopic examination, are required to
more clearly identify the subcellular localization of OCT3.
The effects of stress on motivated behavior are powerful, pervasive, and context-dependent, suggesting complex interactions
between stress-response systems and the circuitry underlying
motivated behavior. However, rather than driving specific behaviors, stress often modulates ongoing behaviors in a contextdependent manner. We have demonstrated a central role for
glucocorticoid hormones in the heightened susceptibility to drug
relapse during times of stress, and we have identified a mechanism by
which stress-level glucocorticoids act in the NAc to decrease dopamine clearance, enhancing the effects of cocaine on dopaminergic
neurotransmission and behavior. This may represent a general
mechanism by which stress, by elevating glucocorticoids, modulates
ongoing behavior, shaping appropriate responses to environmental
stimuli.
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